NO20001045L - Nye cycliske tetrapeptidderivater og medisinsk anvendelse derav - Google Patents

Nye cycliske tetrapeptidderivater og medisinsk anvendelse derav

Info

Publication number
NO20001045L
NO20001045L NO20001045A NO20001045A NO20001045L NO 20001045 L NO20001045 L NO 20001045L NO 20001045 A NO20001045 A NO 20001045A NO 20001045 A NO20001045 A NO 20001045A NO 20001045 L NO20001045 L NO 20001045L
Authority
NO
Norway
Prior art keywords
group
chain
bivalent
cyclic tetrapeptide
carbon atoms
Prior art date
Application number
NO20001045A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001045D0 (no
Inventor
Norikazu Nishino
Minoru Yoshida
Sueharu Horinouchi
Yasuhiko Komatsu
Tsutomu Mimoto
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of NO20001045D0 publication Critical patent/NO20001045D0/no
Publication of NO20001045L publication Critical patent/NO20001045L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12Cyclic peptides with only normal peptide bonds in the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20001045A 1997-09-02 2000-03-01 Nye cycliske tetrapeptidderivater og medisinsk anvendelse derav NO20001045L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23748197 1997-09-02
JP6327098 1998-03-13
PCT/JP1998/003893 WO1999011659A1 (fr) 1997-09-02 1998-09-01 Derives tetrapeptides cycliques et leur utilisation medicinale

Publications (2)

Publication Number Publication Date
NO20001045D0 NO20001045D0 (no) 2000-03-01
NO20001045L true NO20001045L (no) 2000-04-27

Family

ID=26404362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001045A NO20001045L (no) 1997-09-02 2000-03-01 Nye cycliske tetrapeptidderivater og medisinsk anvendelse derav

Country Status (9)

Country Link
US (1) US6399568B1 (fr)
EP (1) EP1010705A4 (fr)
JP (1) JP3494624B2 (fr)
KR (1) KR20010023449A (fr)
AU (1) AU732299B2 (fr)
CA (1) CA2302451A1 (fr)
NO (1) NO20001045L (fr)
NZ (1) NZ503061A (fr)
WO (1) WO1999011659A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822267B1 (en) * 1997-08-20 2004-11-23 Advantest Corporation Signal transmission circuit, CMOS semiconductor device, and circuit board
JP4269041B2 (ja) * 1999-03-02 2009-05-27 国立大学法人九州工業大学 新規な環状テトラペプチド誘導体とその医薬用途
JP2003505417A (ja) * 1999-07-23 2003-02-12 メルク エンド カムパニー インコーポレーテッド アピシジン誘導環状テトラペプチド類
EA200601252A1 (ru) 1999-09-08 2006-10-27 Слоан-Кеттеринг Инститьют Фор Кэнсер Рисёч Новый класс веществ, вызывающих дифференцировку клеток и являющихся ингибиторами гистондеацетилазы, и способы их применения
BR0016154A (pt) 1999-12-08 2003-02-25 Xcyte Therapies Inc Depsipeptida e seus congêneres papa uso como imunossupressores
US6828302B1 (en) 1999-12-08 2004-12-07 Xcyte Therapies, Inc. Therapeutic uses of depsipeptides and congeners thereof
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
CA2457043A1 (fr) 2001-08-21 2003-02-27 Fujisawa Pharmaceutical Co., Ltd. Usage medical d'un inhibiteur d'histone desacetylase et methode d'evaluation de son activite antitumorale
JP2005517683A (ja) * 2001-12-28 2005-06-16 藤沢薬品工業株式会社 環状テトラペプチド化合物およびその用途
WO2003070754A1 (fr) * 2002-02-20 2003-08-28 Minoru Yoshida Inhibiteurs d'histone desacetylase et procede de production de ces inhibiteurs
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
WO2004046312A2 (fr) * 2002-11-15 2004-06-03 The Board Of Trustees Of The University Of Illinois Methodes de developpement in vitro de cellules souches hematopoietiques
JP2006520796A (ja) 2003-03-17 2006-09-14 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼインヒビター
JP4550738B2 (ja) * 2003-06-20 2010-09-22 独立行政法人理化学研究所 ヒストン脱アセチル化酵素阻害剤およびその製造方法
EP1824831A2 (fr) 2004-12-16 2007-08-29 Takeda San Diego, Inc. Inhibiteurs d'histone desacetylase
WO2006122319A2 (fr) 2005-05-11 2006-11-16 Takeda San Diego, Inc. Inhibiteurs d'histone deacetylase
JP2009501236A (ja) 2005-07-14 2009-01-15 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
EP1801115A1 (fr) * 2005-12-23 2007-06-27 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Peptides cycliques et leur utilisation dans le traitement de neuroblastome au stade avancé
JP2007262058A (ja) * 2006-03-03 2007-10-11 Tokyo Univ Of Science 糸状菌の分化抑制剤
EP2012801A4 (fr) 2006-04-24 2009-08-05 Gloucester Pharmaceuticals Inc Thérapie de combinaison de gemcitabine
WO2007146730A2 (fr) 2006-06-08 2007-12-21 Gloucester Pharmaceuticals Thérapie à base d'inhibiteurs de désacétylase (dac)
WO2008029565A1 (fr) 2006-09-05 2008-03-13 Kyushu Institute Of Technology Composé ayant une activité d'inhibition sur l'histone désacétylase et produit pharmaceutique comprenant le composé en tant qu'ingrédient actif
CA2671649A1 (fr) * 2006-12-06 2008-06-12 Sapporo Medical University Potentialisation d'immunite cellulaire au moyen d'inhibiteurs d'histone desacetylase (hdac)
CN101801994A (zh) 2006-12-29 2010-08-11 格洛斯特制药公司 制备Romidepsin
CA2574531C (fr) * 2007-01-19 2016-10-25 The University Of British Columbia Promoteurs de l'acetylation d'hat et utilisations de compositions contenant ceux-ci pour promouvoir l'immunogenicite
KR100909867B1 (ko) * 2007-04-16 2009-07-29 주식회사바이오러넥스 골대사성 질환의 예방 및 치료를 위한 조성물
WO2010006267A2 (fr) * 2008-07-11 2010-01-14 University Of Kansas Tétrapeptides cycliques
CA2804795A1 (fr) 2010-07-12 2012-01-19 Nicholas Vrolijk Formes solides de la romidepsine et leurs utilisations
US8859502B2 (en) 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
WO2012074180A1 (fr) * 2010-12-01 2012-06-07 주식회사바이오러넥스 Nouveaux dérivés tétraazacyclododécane-tétraone ou leurs sels pharmaceutiquement acceptables, et composition pharmaceutique les contenant pour la prévention ou le traitement du cancer
AU2013202506B2 (en) 2012-09-07 2015-06-18 Celgene Corporation Resistance biomarkers for hdac inhibitors
AU2013202507B9 (en) 2012-11-14 2015-08-13 Celgene Corporation Inhibition of drug resistant cancer cells
NZ630311A (en) 2013-12-27 2016-03-31 Celgene Corp Romidepsin formulations and uses thereof
US11325944B2 (en) 2017-06-16 2022-05-10 University Of Florida Research Foundation, Incorporated Macrocyclic peptides and derivatives thereof with opioid activity
EP3461488A1 (fr) 2017-09-27 2019-04-03 Onxeo Combinaison d'une molécule dbait et un inhibiteur de hdac pour le traitement du cancer
EP3461480A1 (fr) 2017-09-27 2019-04-03 Onxeo Combinaison d'inhibiteurs de point de contrôle du cycle cellulaire de réponse à un dommage à l'adn et de belinostat pour traiter le cancer
WO2021148581A1 (fr) 2020-01-22 2021-07-29 Onxeo Nouvelle molécule dbait et son utilisation
EP4405680A1 (fr) 2021-09-20 2024-07-31 Institut National de la Santé et de la Recherche Médicale (INSERM) Procédés pour l'amélioration de l'efficacité d'une thérapie par inhibiteur de hdac et la prédiction de la réponse à un traitement comprenant un inhibiteur de hdac
WO2023194441A1 (fr) 2022-04-05 2023-10-12 Istituto Nazionale Tumori Irccs - Fondazione G. Pascale Combinaison d'inhibiteurs de hdac et de statines pour une utilisation dans le traitement du cancer du pancréas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0334991A (ja) * 1989-06-30 1991-02-14 Shionogi & Co Ltd 環状テトラペプチドおよびその製造法
CA2231251A1 (fr) * 1995-09-20 1997-03-27 Merck & Co., Inc. Histone desacetylase comme cible pour des agents antiprotozoaires
GB2309696B (en) * 1996-01-31 2000-02-23 Merck & Co Inc Antiprotozoal cyclic tetrapeptides
US6777217B1 (en) * 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto

Also Published As

Publication number Publication date
WO1999011659A1 (fr) 1999-03-11
NZ503061A (en) 2001-08-31
AU732299B2 (en) 2001-04-12
CA2302451A1 (fr) 1999-03-11
US6399568B1 (en) 2002-06-04
AU8888598A (en) 1999-03-22
EP1010705A1 (fr) 2000-06-21
EP1010705A4 (fr) 2004-09-15
NO20001045D0 (no) 2000-03-01
JP3494624B2 (ja) 2004-02-09
KR20010023449A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
NO20001045L (no) Nye cycliske tetrapeptidderivater og medisinsk anvendelse derav
BRPI0413232A (pt) novos compostos tendo atividade inibitória contra os trasnportadores dependentes de sódio
FI950309A0 (fi) Proliiniamidijohdannaisia
DK0889876T3 (da) Meta-substituerede phenylensulfonamidderivater
NO974577D0 (no) Tienyl-, furyl-, pyrrolyl- og bifenylsulfonamider og derivater derav som modulerer aktiviteten av endotelin
DK1265606T3 (da) Celleadhæsionsinhibitorer
BR0307575A (pt) Derivados de sulfonila como inibidores de histona desacetilase
ATE156116T1 (de) Auf aromatischen sulfonamiden basierende hydroxamsäurederivate
BR9812095A (pt) Compostos de indol como inibidores de cox-2
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
EA200200708A1 (ru) Производные бензазола и их применение в качестве модуляторов jnk
NO20014225L (no) Nye sykliske tetrapeptid-derivater og anvendelse av dem som legemidler
EA200601235A1 (ru) Производные тиазола
NO963370D0 (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
DE69313051D1 (de) Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
NZ334439A (en) Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa-receptor agonists
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
KR910000638A (ko) 피롤카르복시산 유도체
DK0923576T3 (da) 4-Aminoethoxy-indolderivater som dopamin D2-agonister
EA200600270A1 (ru) Применение производных 2h-[1,3]-оксазино[3,2-a]индола для лечения невропатической боли
TH35496A (th) วิธีการใช้คาร์บาเมตบำรุงประสาทและยูเรีย